Immunotherapy Resistance in dMMR/MSI‐H Colorectal Cancer: Unraveling Mechanisms and Exploring Overcoming Strategies
Colorectal cancer (CRC) remains a leading cause of cancer‐related mortality worldwide. Approximately 15% of localized and 5% of metastatic cases exhibit mismatch repair deficiency (dMMR) or high microsatellite instability (MSI‐H). While immune checkpoint inhibitors (ICIs) have revolutionized the first‐line treatment fo...